LISDEXAMFETAMINE (has an active metabolite) | LISDEXAMFETAMINE | ATC N06BA02
NERVOUS SYSTEM L-LYSINE-D-AMPHETAMINE PSYCHOSTIMULANT CENTRAL NERVOUS SYSTEM STIMULANT INDICATED FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) A PRODRUG OF DEXTROAMPHETAMINE BLOCK THE REUPTAKE OF NOREPINEPHRINE AND DOPAMINE INTO THE PRESYNAPTIC NEURON AND INCREASE THE RELEASE OF THESE MONOAMINES INTO THE EXTRANEURONAL SPACE | ORAL | SOLUBILITY SOLUBLE IN WATER 792 MILLIGRAM / MILLILITER | MONOAMINE TRANSPORTER | Sodium-dependent noradrenaline transporter UNIPROT P23975 SLC6A2 -- Sodium-dependent dopamine transporter UNIPROT Q01959 SLC6A3 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |